|
HS Code |
759621 |
| Cas Number | 83512-85-0 |
| Molecular Formula | Variable (based on degree of substitution), commonly (C8H13NO5)n |
| Appearance | White to off-white powder |
| Solubility | Soluble in water, insoluble in most organic solvents |
| Degree Of Substitution | Typically ranges from 0.4 to 1.2 |
| Molecular Weight | Varies, generally 10,000 - 1,000,000 Da |
| Ph Of 1 Solution | Around 6.0 - 8.0 |
| Biodegradability | Biodegradable |
| Origin | Derived from chitosan/chitin (primarily from crustacean shells) |
| Stability | Stable under dry, cool conditions |
| Charge | Anionic (due to carboxymethyl groups) |
As an accredited Carboxymethyl Chitosan factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Carboxymethyl Chitosan is securely packaged in a 500g, double-sealed aluminum foil pouch with clear labeling for safe handling. |
| Shipping | Carboxymethyl Chitosan is securely packaged in sealed, moisture-proof containers or double-layered polyethylene bags within fiber drums to maintain product stability. It is shipped at ambient temperature, protected from direct sunlight, moisture, and incompatible substances, ensuring safe transit. Proper labeling and documentation are included for regulatory compliance and safe handling. |
| Storage | Carboxymethyl Chitosan should be stored in a cool, dry place, away from direct sunlight, heat sources, and moisture. Keep the container tightly closed to prevent contamination and degradation. Ideally, storage should be at room temperature or below, in a well-ventilated area. Avoid exposure to strong acids, oxidizing agents, and incompatible substances. Always follow safety guidelines and supplier recommendations. |
Applications of Carboxymethyl Chitosan in Industrial ManufacturingOur factory-grade Carboxymethyl Chitosan serves advanced industries requiring reliable bio-based functional raw materials. Below, we detail specialized application scenarios, specifications, process integrations, and common downstream end products across major industrial sectors. 1. Pharmaceutical Wound Dressing ManufacturingPharmaceutical companies incorporate Carboxymethyl Chitosan as a bioactive agent in hydrogel and non-woven wound dressings due to its biocompatibility, moisture retention, and antibacterial properties. Manufacturers must consider sterilization stability and avoid introducing allergens or impurities during the formulation stage. Standard production uses it as a binder or direct coating agent, where final dressings or films must meet strict medical device standards. Controlled blending with other polysaccharides, crosslinkers, and saline solutions allows forming customizable hydrogels adapted to many clinical indications for acute or chronic wound management. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Dietary Supplement FormulationHealth supplement manufacturers use Carboxymethyl Chitosan as a soluble dietary fiber with demonstrated cholesterol-lowering and digestive benefits. It enables the development of prebiotic powder blends, coated tablets, and functional beverages. The material is incorporated during wet or dry granulation, often mixed with vitamins, minerals, or plant extracts. All handling steps must prevent cross-contamination and meet food-grade purity levels. Finished goods target regulated markets demanding accurate labeling and ingredient transparency for consumers and regulators alike. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Biodegradable Agricultural Film ProductionCarboxymethyl Chitosan finds use as a film-forming agent and soil conditioner in agricultural mulch film and seed coating manufacture, promoting sustainable crop management. Process engineers tailor viscosity and degradation rates by optimizing the polysaccharide concentration with plasticizers or glycerol. Strict agricultural materials directives guide chemical input limits and field safety testing. After blending and extrusion, the compound supports controlled release of nutrients and degrades safely following crop cycles to minimize plastic residue buildup in soil. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Cosmetic Skin Care FormulationMajor cosmetic manufacturers select Carboxymethyl Chitosan for anti-inflammatory, moisturizing, and film-forming properties in advanced skin care. Product development teams incorporate it during emulsion or hydrosol preparation, ensuring molecular weight and substitution levels meet skin tolerance and safety requirements. Integration into production lines occurs before homogenization and filling, optimizing viscosity and spreadability for target creams, serums, and facial masks. Quality management focuses on batch consistency, free amino content, and microbiological purity matching regional cosmetic safety protocols. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Textile Fiber TreatmentTextile finishers employ Carboxymethyl Chitosan as a sustainable coating agent to enhance fiber strength, impart antimicrobial functionality, and boost dye uptake in natural and blended fabrics. It enters production after bleaching and scouring, typically dissolving in aqueous solutions with crosslinkers or functional modifiers for padding or exhaustion techniques. Treated textiles must comply with regulations governing extractable substances and wearable safety. The process supports eco-friendly positioning for apparel, medical, and technical textiles. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Carboxymethyl Chitosan prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: admin@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Decades of hands-on work with natural polymers have shaped how we approach Carboxymethyl Chitosan (CMC). Shifting chitosan derivatives from theory to large-scale production reveals the difference between chasing novelty and backing a material that data supports. The underlying chemistry in CMC—combining chitin with targeted carboxymethyl substitution—earned its reputation in laboratories because it delivers tangible results across real industries.
CMC’s properties stem from functional changes at the molecular level. By converting chitosan’s amino groups into carboxymethyl units, we get a water-soluble powder that opens possibilities for solution formulations and blends. Hydration in cold water remains predictable, which saves time and effort for processors. We manufacture several models with differing degrees of substitution and viscosity, since each use—whether in biomedical, cosmetic, or agricultural sectors—calls for fine tuning these parameters. We run tests every day in our own facility, not just to satisfy minimum quality marks, but to see how slight shifts in molecular architecture reveal performance edges for each application.
As a manufacturer, we don’t believe in one-size-fits-all. Our product line covers a spread of viscosities and substitution rates to support everything from injectable hydrogels for medical research to soil conditioners for high-value crops. Most customers in the medical device or drug delivery sector request a high-purity, low endotoxin grade, so we adapted processes to target clean, white powder with consistent degree of carboxymethylation. In our experience, wound dressing designers often pick medium viscosity CMC. The reason is clear: it strikes the right balance between film-forming ability and manageable rehydration.
Agricultural users favor versions that keep a stable solution at varied pH and remain resistant to microbial breakdown, giving additives a longer window to act on plants or soil. For cosmetics, the focus turns to clarity in water, skin compatibility, and a tactile, non-tacky finish. We gather these requirements through direct feedback and by testing finished products that rely on our raw materials. Every batch undergoes viscosity, solubility, and purity tests with reference chemical standards. Years of tuning the reactor feed rates, pH, and post-treatment steps taught us how to eliminate erratic color, prevent gelling hotspots, and track salt content.
Compared to traditional food and pharma thickeners—like sodium alginate or cellulose derivatives—CMC holds an edge in biocompatibility and functional group density. The combined amine and carboxyl functionalities create a strong scaffold for many uses. In water, solutions remain clear at low concentrations, minimizing clouding in transparent gels or films. Manufacturers who switched from plain chitosan noticed a difference right away: CMC dissolves in both acidic and neutral media, which removes a major barrier in formulating efficient aqueous systems.
Standard chitosan dissolves only under acidic conditions and forms cloudy, unstable solutions when pH climbs above 6. CMC’s solubility profile removes this bottleneck. For us, this meant less downtime from clogged pumps and inconsistent mixing. It also paved the way for streamlined production lines with reduced need for acidification or neutralization steps. Downstream processors tell us this shift drops costs and simplifies their compliance burden.
CMC’s carboxymethyl groups increase negative surface charge, which amplifies its ability to form polyelectrolyte complexes with proteins or other charged polymers. This gives CMC-based medical dressings a controlled moisture profile and soothes sensitive skin. From a maintenance standpoint, the increased hydrophilicity supports shelf-life and storage—clumping, yellowing, or premature crosslinking rarely crop up if produced to tight standards. We monitor for this batch by batch.
Transforming chitosan from crustacean shells into advanced CMC involves steps that demand vigilance. The raw chitin comes with baggage—protein, minerals, and pigment. Each can trip up modification if not handled. By running demineralization and deproteinization phases under continuous monitoring, we strip non-essential impurities before derivatization. These steps protect against the “off-smell” and discoloration sometimes found in poorly prepared samples.
The alkali steps, temperature controls, and reaction duration determine much about CMC’s utility. Too little conversion results in a powder that dissolves poorly. Excessive modification can degrade the backbone, leaving a weak, brownish material. In our shop, we learned that walking this line between incomplete and overdone separation comes from knowing your batch, not your spreadsheet. Each move on the line—adjusting sodium monochloroacetate feed or holding slurry at just the right temperature—touches final purity and reproducibility.
We take environmental and worker safety as seriously as end-product performance. Chitosan offers many “green” claims, but reality requires checking solvent recycling, effluent treatment, and minimizing byproduct release at every reaction step. Saxons of practice—like vacuum filtration instead of gravity settling, or careful PH step-down—turned out to cut water use and improve product grades. Every process tweak and upgrade traces back to direct observation.
Anyone in manufacturing knows that customer conversations drive product selection toward real-world needs. We hear from medical device engineers looking for CMC that won’t activate immune response, from formulators who have concerns about microbial contamination, and from fertilizer companies needing CMC to extend active lifespan of nutrients. These are not abstract concerns but production challenges showing up in daily plant performance.
Medical clients, for instance, test for pyrogen content and require documentation down to the lot. Our process engineers maintain logs and sample every lot for NV (nitrogen value), viscosity, particle size, and residual solvents. This level of traceability didn’t appear overnight. It came from years of regulatory audits and demanding users pushing each step to meet new thresholds. We don’t mind when someone sends back a sample with questions or requests a custom substitution rate—these exchanges shape improvements in plant SOP and add to our collective experience.
Traditional chitosan—while abundant—forces users to operate at lower pH levels to keep products stable. Hydroxypropyl chitosan, another derivative, brings better solubility in neutral conditions but fails to match the moisture management and film mechanical strength seen in CMC when both are compared at equal substitution degrees. Carboxymethyl cellulose, perhaps the most widely known “CMC,” differs from our chitosan version in biodegradability and bioactivity; it focuses on bulk texturizing rather than interfaces with living tissues.
The blend of carboxymethyl and amine groups gives CMC better metal-chelating properties and a more adaptable backbone for functionalization. This serves researchers targeting novel drug conjugates and skin-care actives. The backbone’s inherent antimicrobial potential stands out as well, which is why so many wound care products and seed coatings leverage CMC instead of classic alternatives. Oral care and veterinary products land on CMC for similar reasons: high charge density improves adherence and retention times in formulations, while solubility takes away formulation headaches.
Building a reliable supply chain for CMC takes more than just capacity. Crustacean shell sources change with fishing landscapes, and not all chitin is created equal. Marine byproducts gathered from regions with excessive heavy metal content yield chitosan that can slip past basic screening but trigger downstream performance failures. We learned early to keep procurement strict—traceability to fishing zone, coupled with multi-stage internal testing, keeps problem lots out of the reactor.
Production volumes swing based on season, regulatory action, and sudden spikes in demand. Recently, medical diagnostics and hydrogel research climbed fast, putting strain on supply. We keep stocks on hand and run parallel lines as risk mitigation. Knowing our process bottlenecks—filtration slowdowns, drying inconsistences, raw input variability—prevents us from overpromising and preserves trust across our customer base.
We field ongoing requests from university labs and independent researchers for CMC with particular chain lengths, substitution levels, or purity profiles. The demand for ultra-low endotoxin, DNA-free raw material to back clinical batches, has only increased. In response, we dedicated more reactor time to specialty lots. This allows scientists to avoid fresh batch development for every trial, keeping their focus on application rather than raw input troubleshooting.
Our technical staff stays in regular contact, offering insights into dissolution practices, shelf-life, and interaction with other ingredients in complex blends. This approach, born from years of witnessing what works and what leads to costly revalidation, keeps projects advancing.
Scientists and clinicians rely on CMC for more than just its status as a chitosan derivative. Glycosaminoglycan-mimicry—something our CMC achieves thanks to its functional group profile—allows cell interaction studies, slow-release matrices, and absorbable films. In our shop, teams started with small-batch prototypes for university partners, then expanded to kilogram-scale lots for regulated device makers. Mouse-to-human translation brings calls for documentation, batch consistency, and full characterization. We meet these checkpoints with in-house analytics and stepwise documentation.
In tissue scaffolds and wound management, the purity, solubility, and moisture-binding capacity predicted by analytic numbers match what doctors and nurses see at point-of-care. If a sample fails hydration or stales on storage, it never leaves our facility. Negative field feedback gets addressed with process tweaks. For drug delivery, chain length, substitution pattern, and impurity profile direct drug release rates and compatibility. Over time, this direct feedback loop between manufacturer, researcher, and end user gave us a map of pitfalls—and actionable fixes—in scaling up.
Personal care brands investing in “bio-based” claims search for ingredients with safety records and long histories of use. CMC brings more than just marketing value. Our partners report improved emulsion stabilization, lighter after-feel in gels, and better moisture management in creams without heavy occlusion. We ran side-by-side formulation tests at in-house pilot labs to validate these claims, seeing real differences compared to previous batches using plain chitosan or sodium alginate as a base. The powder integrates easily in cold-water systems, cutting back on production time and reducing caking on mixing lines.
Aside from ease of use, safety issues push adoption. The well-documented biocompatibility and low toxicity (backed by peer-reviewed studies) set minds at ease. We keep a close watch on every input and sampling step to lock out contaminants that could disrupt this profile. Final lots undergo not only the usual heavy metal and microbe counts but also protein and endotoxin screenings, particularly for batches targeting leave-on skin products.
Growing numbers of controlled-release fertilizer and soil health companies now hold up CMC as an upgrade over synthetic binders and coatings. Our agriculture customers share that CMC extends fungicide or nutrient release, reducing runoff and maintaining plant health through critical stages. In field trials, formulations with CMC withstand variable weather better than conventional binders; soil microorganisms break it down only after the target delivery window closes.
We visited agricultural fields with partners and saw firsthand how CMC-blend coatings prevent granule caking. Smoother, lighter coatings hold up during equipment loading and application across large-acreage fields. This matches the granular flow data and storage findings from our in-factory trials. Recycling of field runoff and improved groundwater results—attributed to the biodegradable, marine-origin backbone—lets us stand behind environmental claims with actual numbers, not just marketing spin.
Our confidence in Carboxymethyl Chitosan comes from years of hands-on process improvement and transparent feedback from buyers and users. Each step, from raw shell sourcing to powder drying and packaging, shows up in real-world results. Failures, corrections, and incremental gains have reshaped how we react to new applications and market requirements.
We rely on factual production data—batch by batch—to verify quality, not just the label. Product consistency and flexibility grow from knowing what pitfalls lurk in each process stage, and addressing them before powder leaves our warehouse. Every sample request, audit, or off-spec notification builds our experience. The lessons uncovered along the way let us push Carboxymethyl Chitosan beyond its original boundaries and into innovations our partners drive.
Future developments point toward more uses in pharmaceuticals, regenerative medicine, and environmentally friendly formulations as regulations tighten and consumers expect more from their raw materials. The foundation rests on rigorous process management and honest, open exchanges with those who depend on us. We see each kilogram as a trust, not just a product: one grounded in science, adapted by industry, and maintained by people who know—and care—about what goes into every batch.